Skip to main content
. 2018 Jul 5;8:10175. doi: 10.1038/s41598-018-28490-y

Figure 1.

Figure 1

Diminazene aceturate (DIZE) treatment inhibited hepatobiliary fibrosis in mice. DIZE reduced the activation of hepatic stellate cells, as reflected by a reduced expression of α-smooth muscle actin (α-SMA) (A,E) and extracellular matrix protein, collagen 1 (B) leading to a marked reduction in biliary fibrosis (C,D) in both BDL and Mdr2-KO mice. Positive brown color staining for liver α-SMA by immunohistochemistry (arrows in panel E) and picrosirius red staining of bridging fibrosis (arrows in panel C) and fibrosis around portal triads (arrow heads in panel C) are shown (×200). Each bar represents the mean ± SEM profile from 10–15 mice per treatment group.